previous next

Working Toward Quality Compounded Drugs: A Critical Partnership

This week Congress will hold an important and timely hearing on compounded drugs. The hearing brings stakeholders together to reflect on a law enacted nearly five years ago in response to serious public health incidents. In 2012, a nationwide fungal meningitis outbreak originating from contaminated injectable compounded sterile drugs sickened over 750 individuals and resulted in the deaths of more than 70.

Share

Opioid Crisis: USP’s Comments to the FDA

As government agencies consider solutions to the growing opioid crisis, the Food and Drug Administration (FDA) recently sought public comment about ways to best address this national emergency. USP was pleased to provide our perspective about how public standards might help support the agency’s efforts, and to report on our recent discussions with stakeholders and the standards being considered by USP’s Healthcare Quality Expert Committee.  

Share

Protecting Medicines Quality in Africa: USP presents at 3rd Biennial Scientific Conference on Medical Products Regulation

Protecting Medicines Quality in Africa

Countries throughout Africa are working to harmonize standards to make processes more efficient and help bring needed pharmaceuticals to market, while protecting medicines quality. Learn more

Share

Pages

Related Stories

Increasing the sources of quality medicines in LMICs: Challenges and strategies
Increasing the sources of quality medicines in LMICs: Challenges and strategies
USP Excipient Monographs & Standards
USP Excipient Monographs & Standards
Characterization of Biologics: USP Standards
Medicine Quality Assurance: USP's Technical Review Program